[go: up one dir, main page]

HN2001000013A - PIRIDO [2,3 - d] PIRIMIDIN - 2, 7 - DIAMINAS INHIBIDORES DE CINASAS - Google Patents

PIRIDO [2,3 - d] PIRIMIDIN - 2, 7 - DIAMINAS INHIBIDORES DE CINASAS

Info

Publication number
HN2001000013A
HN2001000013A HN2001000013A HN2001000013A HN2001000013A HN 2001000013 A HN2001000013 A HN 2001000013A HN 2001000013 A HN2001000013 A HN 2001000013A HN 2001000013 A HN2001000013 A HN 2001000013A HN 2001000013 A HN2001000013 A HN 2001000013A
Authority
HN
Honduras
Prior art keywords
pirido
pirimidin
diamines
kinase inhibiting
enzymes
Prior art date
Application number
HN2001000013A
Other languages
English (en)
Spanish (es)
Inventor
Booth Richard John
Dobrusin Ellen Myra
Josyula Vara Prasad Venkata Nagendra
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HN2001000013A publication Critical patent/HN2001000013A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
HN2001000013A 2000-01-25 2001-01-24 PIRIDO [2,3 - d] PIRIMIDIN - 2, 7 - DIAMINAS INHIBIDORES DE CINASAS HN2001000013A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17826100P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
HN2001000013A true HN2001000013A (es) 2001-06-18

Family

ID=22651853

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000013A HN2001000013A (es) 2000-01-25 2001-01-24 PIRIDO [2,3 - d] PIRIMIDIN - 2, 7 - DIAMINAS INHIBIDORES DE CINASAS

Country Status (34)

Country Link
EP (1) EP1254137A1 (et)
JP (1) JP4047010B2 (et)
KR (1) KR20020065939A (et)
CN (1) CN1395578A (et)
AP (1) AP2002002586A0 (et)
AR (1) AR030044A1 (et)
AU (1) AU2542501A (et)
BG (1) BG106850A (et)
BR (1) BR0107751A (et)
CA (1) CA2397961C (et)
CO (1) CO5261549A1 (et)
CR (1) CR6706A (et)
CZ (1) CZ20022475A3 (et)
DZ (1) DZ3266A1 (et)
EA (1) EA200200643A1 (et)
EE (1) EE200200405A (et)
GT (1) GT200100016A (et)
HN (1) HN2001000013A (et)
HU (1) HUP0204141A3 (et)
IL (1) IL150545A0 (et)
IS (1) IS6443A (et)
MA (1) MA26868A1 (et)
MX (1) MXPA02007221A (et)
NO (1) NO20023527L (et)
OA (1) OA12161A (et)
PA (1) PA8510701A1 (et)
PE (1) PE20011066A1 (et)
PL (1) PL356802A1 (et)
SK (1) SK10632002A3 (et)
SV (1) SV2002000294A (et)
TN (1) TNSN01014A1 (et)
WO (1) WO2001055147A1 (et)
YU (1) YU50402A (et)
ZA (1) ZA200205879B (et)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235551B2 (en) 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
CN1847229B (zh) 2000-10-23 2011-05-04 史密丝克莱恩比彻姆公司 2，4，8-三取代-8H-吡啶并[2，3-d]嘧啶-7-酮化合物
PE20030008A1 (es) * 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
EP1499320B1 (en) 2002-04-19 2007-08-22 Smithkline Beecham Corporation Novel compounds
US7504410B2 (en) * 2002-11-28 2009-03-17 Schering Aktiengesellschaft Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
US7157455B2 (en) * 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
EP1794160A1 (en) * 2004-09-21 2007-06-13 F.Hoffmann-La Roche Ag 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors
EP1868612A4 (en) 2005-03-25 2010-03-24 Glaxo Group Ltd NOVEL CONNECTIONS
PE20061193A1 (es) 2005-03-25 2006-12-02 Glaxo Group Ltd DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
UY29440A1 (es) 2005-03-25 2006-10-02 Glaxo Group Ltd Nuevos compuestos
CN101495475A (zh) 2005-03-25 2009-07-29 葛兰素集团有限公司 制备吡啶并[2,3-d]嘧啶-7-酮和3,4-二氢嘧啶并[4,5-d]嘧啶-2(1H)-酮衍生物的方法
FR2887882B1 (fr) 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
CN101243081A (zh) * 2005-07-21 2008-08-13 霍夫曼-拉罗奇有限公司 作为PTP1B抑制剂的吡啶并[2,3-d]嘧啶-2,4-二胺化合物
BRPI0614804A2 (pt) * 2005-08-09 2011-04-12 Irm Llc compostos e composições como inibidores de proteìna cinase
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
EP1914234A1 (en) 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
JO2985B1 (ar) 2006-12-20 2016-09-05 Takeda Pharmaceuticals Co مثبطات كينازmapk/erk
FR2910813B1 (fr) * 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
EP2112150B1 (en) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Improved raf inhibitors
EP2352732B1 (en) * 2008-12-01 2013-02-20 Merck Patent GmbH 2,5-DIAMINO-SUBSTITUTED PYRIDO[4, 3-d]PYRIMIDINES AS AUTOTAXIN INHIBITORS AGAINST CANCER
GB201104267D0 (en) 2011-03-14 2011-04-27 Cancer Rec Tech Ltd Pyrrolopyridineamino derivatives
GB201216018D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Pharmacologically active compounds
GB201216017D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Inhibitor compounds
ES2817448T3 (es) 2013-03-14 2021-04-07 Icahn School Med Mount Sinai Compuestos de pirimidina como inhibidores de quinasas
GB201403536D0 (en) 2014-02-28 2014-04-16 Cancer Rec Tech Ltd Inhibitor compounds
KR101671404B1 (ko) * 2014-09-02 2016-11-02 한국원자력의학원 항암 효과, 방사선 병용치료 효과 및 당뇨병 치료 효과를 갖는 피리미딘 유도체 및 이의 의학적 용도
CN107286180B (zh) * 2016-04-11 2019-07-02 上海勋和医药科技有限公司 杂代吡啶并嘧啶酮衍生物作为cdk抑制剂及其应用
GB201709840D0 (en) 2017-06-20 2017-08-02 Inst Of Cancer Research: Royal Cancer Hospital Methods and medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281724B6 (sk) * 1994-11-14 2001-07-10 Warner-Lambert Company 6-arylpyrido[2,3-d]pyrimidíny, ich použitie a farmaceutické prostriedky na ich báze
IL115256A0 (en) * 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
US5620981A (en) * 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
KR20010043829A (ko) * 1998-05-26 2001-05-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 세포 증식 억제제로서의 비시클릭 피리미딘 및 비시클릭3,4-디히드로피리미딘

Also Published As

Publication number Publication date
EA200200643A1 (ru) 2002-12-26
OA12161A (en) 2006-05-08
PE20011066A1 (es) 2001-10-22
AP2002002586A0 (en) 2002-09-30
ZA200205879B (en) 2003-09-29
WO2001055147A1 (en) 2001-08-02
SV2002000294A (es) 2002-07-16
EP1254137A1 (en) 2002-11-06
YU50402A (sh) 2005-11-28
IS6443A (is) 2002-06-25
BG106850A (bg) 2003-02-28
GT200100016A (es) 2001-10-19
IL150545A0 (en) 2003-02-12
PL356802A1 (en) 2004-07-12
CN1395578A (zh) 2003-02-05
CA2397961C (en) 2008-08-26
NO20023527L (no) 2002-09-10
CA2397961A1 (en) 2001-08-02
CO5261549A1 (es) 2003-03-31
EE200200405A (et) 2003-12-15
MA26868A1 (fr) 2004-12-20
AU2542501A (en) 2001-08-07
DZ3266A1 (fr) 2001-08-02
AR030044A1 (es) 2003-08-13
JP2003523357A (ja) 2003-08-05
CR6706A (es) 2005-04-04
PA8510701A1 (es) 2002-12-11
NO20023527D0 (no) 2002-07-24
HUP0204141A2 (hu) 2003-04-28
JP4047010B2 (ja) 2008-02-13
HUP0204141A3 (en) 2005-03-29
SK10632002A3 (sk) 2003-06-03
KR20020065939A (ko) 2002-08-14
CZ20022475A3 (cs) 2003-03-12
BR0107751A (pt) 2002-11-12
TNSN01014A1 (fr) 2005-11-10
MXPA02007221A (es) 2002-11-29

Similar Documents

Publication Publication Date Title
HN2001000013A (es) PIRIDO [2,3 - d] PIRIMIDIN - 2, 7 - DIAMINAS INHIBIDORES DE CINASAS
USD538050S1 (en) Substrate with camouflage pattern
IS7319A (is) Fjölgervingar klópídógrelvetnissúlfats
CR6736A (es) 5-alquilpirido[2,3-d[ piridinas como inhibidores de tirosina kinasa
HN1999000083A (es) Compuestos de pirrolo(2,3-d) pirimidina
WO2004044158A3 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
BR0010616A (pt) Sequências de ácido nucléico a proteìnas envolvidas em sìntese de isoprenóide
BG106035A (en) Heterocyclically substituted benzimidazoles, the production and utilization thereof
BR0308339A (pt) Indazóis substituìdos com uma atividade anticancerosa
AP1758A (en) Method for the preparation of hexahydro-furo [2,3-b]furan-3-ol.
BRPI0414598A (pt) indóis substituìdos
AU1783201A (en) 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
TNSN08069A1 (en) Amorphous solid dispersions of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5,-dihydro-4h-pyridazino[4,5 b] indole -1- acetamide
HN1997000098A (es) Ccompuesto de indol 2, 3 sustituido como agentes antiinflamatorios y analgesicos.
AU5354301A (en) Nucleic acid sequences to proteins involved in tocopherol synthesis
AU1781601A (en) 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
WO2002056929A3 (en) Implant with porous calcium phosphate surface layer
USD490248S1 (en) Tissue with embossed puppy design
USD479281S1 (en) Board game for teaching DNA concepts
WO2003070878A3 (en) Antisense modulation of hematopoietic cell protein tyrosine kinase expression
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
AR023979A1 (es) Procesos para preparar compuestos intermedios de plaguicidas
USD506316S1 (en) Surface pattern for fabric
HN2000000078A (es) Amidas sustituidas del acido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporacion de adenosina
WO2005102043A3 (en) Use of nickel to correct growth disorders in plants